Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 98 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjects

Singhal Neha, Praveen V P, Bhavani Nisha, Menon Arun S, Menon Usha, Abraham Nithya, Kumar Harish, JayKumar R V, Nair Vasantha, Sundaram Shanmugha, Sundaram Padma

Year : 2016| Volume: 20| Issue : 2 | Page no: 157-161

   This article has been cited by
1 99mTc-pertechnetate thyroid scintigraphy predicts clinical outcomes in personalized radioiodine treatment for Graves’ disease
Zhao Lina,Zhang Wenqi,Xin Yubo,Wen Qiang,Bail Lin,Guan Feng,Ji Bin
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 2018;
[Pubmed]  [Google Scholar] [DOI]
2 Predicción de los resultados clínicos en el tratamiento personalizado con yodo radiactivo de la enfermedad de Graves, mediante gammagrafía tiroidea con 99mTc-pertecnetato
L. Zhao,W. Zhang,Y. Xin,Q. Wen,L. Bail,F. Guan,B. Ji Bin
Revista Española de Medicina Nuclear e Imagen Molecular. 2018;
[Pubmed]  [Google Scholar] [DOI]
3 Percentage and function of CD4+CD25+ regulatory T cells in patients with hyperthyroidism
Ting-Jun Jiang,Xue-Liang Cao,Sha Luan,Wan-Hui Cui,Si-Huang Qiu,Yi-Chao Wang,Chang-Jiu Zhao,Peng Fu
Molecular Medicine Reports. 2017;
[Pubmed]  [Google Scholar] [DOI]
4 Graves’ Disease in Senegal: Clinical and Evolutionary Aspects
A. Sarr,D. Diédhiou,N. M. Ndour-Mbaye,D. Sow,I. M. Diallo,S. El Alaoui,M. Diouf,S. N. Diop
Open Journal of Internal Medicine. 2016; 06(03): 77
[Pubmed]  [Google Scholar] [DOI]


Read this article